Stock Events

Stock Events

KalVista Pharmaceuticals (4XC1.F) Q3 2024 Earnings

11JulConfirmed

Q2 2023

Q3 2023

Q1 2024

Q3 2024

-0.94

-0.84

-0.75

-0.66

Details

Expected EPS

-0.65567224431

Actual EPS

-0.9384714000000001

Surprise EPS

-0.28

Surprise Percent

+43.13%

Description

KalVista Pharmaceuticals (4XC1.F) has reported earnings of -0.9384714000000001 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.